We are live on ! Find out more
EWM

Elite Wealth Management Portfolio holdings

AUM $337M
1-Year Est. Return 26.14%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+26.14%
3 Year Est. Return
+141.66%
5 Year Est. Return
+159.25%
10 Year Est. Return
AUM
$137M
AUM Growth
+$23.2M
Cap. Flow
+$13.1M
Cap. Flow %
9.58%
Top 10 Hldgs %
48.65%
Holding
1,007
New
568
Increased
105
Reduced
87
Closed
111

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.87M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$3.19M
3
F icon
Ford
F
+$2.88M
4
PM icon
Philip Morris
PM
+$2.78M
5
APA icon
APA Corp
APA
+$2.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.66M
2
NOV icon
NOV
NOV
+$1.99M
3
TXN icon
Texas Instruments
TXN
+$1.81M
4
RTX icon
RTX Corp
RTX
+$1.81M
5
ALL icon
Allstate
ALL
+$1.78M

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.18%
2 Technology 17.35%
3 Consumer Discretionary 9.84%
4 Financials 9.15%
5 Consumer Staples 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWLT
501
DELISTED
FOSTER WHEELER AG (SWITZERLAND)
FWLT
$4K ﹤0.01%
+114
New +$3.33K
SSRI
502
DELISTED
Silver Standard Resources
SSRI
$4K ﹤0.01%
+590
New +$3.57K
CIT
503
DELISTED
CIT Group Inc.
CIT
$4K ﹤0.01%
+74
New +$3.68K
ADM icon
504
Archer Daniels Midland
ADM
$41.7B
$3K ﹤0.01%
+78
New +$3.15K
AGCO icon
505
AGCO
AGCO
$8.67B
$3K ﹤0.01%
+45
New +$2.68K
AIG icon
506
American International
AIG
$39.7B
$3K ﹤0.01%
+67
New +$3.34K
ALL icon
507
Allstate
ALL
$65B
$3K ﹤0.01%
52
-33,315
-100% -$1.78M
BMRN icon
508
BioMarin Pharmaceuticals
BMRN
$12.5B
$3K ﹤0.01%
+43
New +$2.92K
BXP icon
509
PUT
Boston Properties
BXP
$10.2B
$3K ﹤0.01%
+184
New +$19K
CCJ icon
510
Cameco
CCJ
$39.7B
$3K ﹤0.01%
+122
New +$2.37K
CMA
511
DELISTED
Comerica
CMA
$3K ﹤0.01%
+67
New +$2.94K
ENB icon
512
Enbridge
ENB
$106B
$3K ﹤0.01%
+78
New +$3.29K
EW icon
513
Edwards Lifesciences
EW
$49.4B
$3K ﹤0.01%
+240
New +$2.71K
EWM icon
514
iShares MSCI Malaysia ETF
EWM
$314M
$3K ﹤0.01%
53
EXPE icon
515
Expedia Group
EXPE
$35.2B
$3K ﹤0.01%
+42
New +$2.47K
FLR icon
516
Fluor
FLR
$7.23B
$3K ﹤0.01%
+41
New +$3.13K
GDX icon
517
CALL
VanEck Gold Miners ETF
GDX
$28.3B
$3K ﹤0.01%
35
HLF icon
518
Herbalife
HLF
$1.25B
$3K ﹤0.01%
+64
New +$2.22K
HON icon
519
Honeywell
HON
$64.5B
$3K ﹤0.01%
+36
New +$2.81K
HXL icon
520
Hexcel
HXL
$6.91B
$3K ﹤0.01%
+78
New +$3.29K
ITRI icon
521
Itron
ITRI
$4.04B
$3K ﹤0.01%
+65
New +$2.76K
KO icon
522
PUT
Coca-Cola
KO
$382B
$3K ﹤0.01%
+237
New +$9.35K
KSS icon
523
Kohl's
KSS
$1.85B
$3K ﹤0.01%
+56
New +$3.07K
LXU icon
524
LSB Industries
LXU
$822M
$3K ﹤0.01%
+82
New +$2.12K
ORLY icon
525
O'Reilly Automotive
ORLY
$68.9B
$3K ﹤0.01%
+345
New +$2.91K

Similar funds

Elite Wealth Management's Q4 2013 Portfolio in Review

As of Q4 2013, Elite Wealth Management held 1,007 positions worth $137M, up 20% from $113M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Elite Wealth Management deployed $13.1M of net new capital in Q4 2013, opening 568 new positions and adding to 105 existing holdings. Its largest new stake was Union Pacific: 12,440 shares worth $1.04M.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $2.66M trimmed.

  • Elite Wealth Management's largest Q4 2013 buy was Union Pacific: 12,440 shares worth $1.04M.
  • Elite Wealth Management added most to Johnson & Johnson in Q4 2013, an estimated $3.87M increase.
  • Elite Wealth Management's biggest Q4 2013 reduction was Pfizer, cutting an estimated $2.66M.
  • Elite Wealth Management fully exited Texas Instruments in Q4 2013, selling an estimated $1.81M.
  • Elite Wealth Management's ten largest holdings make up 49% of its $137M portfolio in Q4 2013.
  • Elite Wealth Management opened 568 new positions and closed 111 in Q4 2013.
  • Elite Wealth Management's portfolio value rose 20% quarter-over-quarter to $137M.

Based on Elite Wealth Management's 13F filing for Q4 2013, filed 23 Nov 2016.